newsfilter
← Latest News
GlobeNewswire·

Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates

MIAMI, March 08, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the